(Q51887168)

16 April 2018

title

Radiofrequency ablation for treatment of sporadic angiomyolipoma. (English)

1 reference

16 April 2018

author name string

Warner Prevoo

series ordinal

1

1 reference

16 April 2018

Maurice A A J van den Bosch

series ordinal

2

1 reference

16 April 2018

Simon Horenblas

series ordinal

3

1 reference

16 April 2018

language of work or name

English

0 references

publication date

2 May 2008

1 reference

16 April 2018

published in

Urology

1 reference

16 April 2018

volume

72

1 reference

16 April 2018

issue

1

1 reference

16 April 2018

page(s)

188-191

1 reference

16 April 2018

Angiomyolipoma: computed tomographic-pathologic correlation of 17 cases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

The natural history of renal angiomyolipoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Renal angiomyolipoma: long-term results after arterial embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Elective embolization for prevention of hemorrhage from renal angiomyolipomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Management of renal angiomyolipoma: analysis of 15 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Radio-frequency ablation of renal cell carcinoma: early clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Percutaneous radio frequency ablation of small renal tumors: initial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Reporting standards for percutaneous thermal ablation of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Radiofrequency ablation: variability in heat sensitivity in tumors and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

MRI-guided radiofrequency ablation of breast cancer: preliminary clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Nephron-sparing surgery for renal angiomyolipoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

Renal angiomyolipoma: selective arterial embolization--effectiveness and changes in angiomyogenic components in long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

The management of renal angiomyolipoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.02.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2008.02.059

1 reference

16 April 2018

1 reference

16 April 2018